U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711587) titled 'Diaplex and Glycemic Control' on July 13.
Brief Summary: The goal of this 16-week double-blind, placebo-controlled pilot study is to determine whether daily Diaplex supplementation improves insulin sensitivity and glycemic control in adults with elevated blood glucose levels, while generating high-quality preliminary data on metabolic effects, glycemic patterns, and safety to inform future trials
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Insulin Sensitivity
Healthy Adult
Intervention:
DIETARY_SUPPLEMENT: Diaplex
Standard Process Diaplex product
DIETARY_SUPPLEMENT: Placebo
Placebo with no chormium ingr...